Project Grant R01DK143368
Award Date
9/20/24
Completion Date
8/31/28
Dollars Obligated
$551K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute of Diabetes and Digestive and Kidney Diseases
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90095, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will provide $171,450.00 to investigate the biological mechanisms linking excess body fat (adiposity) and elevated blood lipid levels, and their combined impact on cardiovascular disease risk. The research, led by Dr. Dron, a computational geneticist, aims to: 1) measure how adiposity interacts with genetic variants to influence lipid levels, 2)...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $129,137 to the University of California, Los Angeles (UCLA) to examine the role of long noncoding RNAs (lncRNAs) in hepatic lipid metabolism and their potential implications for cardiovascular and metabolic diseases. The primary objectives are to (1) investigate the influence and mechanism of the lncRNA XTENDR on hepatic lipid homeostasis and sex-specific hepatic...
This $3.5 million project grant from the National Institutes of Health's National Institute on Aging will fund research into sex differences related to epigenetic parent-of-origin effects and Alzheimer's disease. The Regents of the University of California, San Francisco will investigate how the maternal versus paternal X chromosome impacts neural vulnerability to Alzheimer's-related deficits in mouse models and primary neurons. The researchers hypothesize that imprinting or silencing of genes...
This Project Grant award of $765,571 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund research to investigate placental essential fatty acid (EFA) metabolism in gestational diabetes mellitus (GDM), with a focus on examining sexual dimorphism in cellular responses. The research aims to define the mechanisms underlying differential responses of male and...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $198,549 to The Regents of the University of California, San Francisco to conduct research on the synergistic effects of menopause and HIV on cardiovascular disease risk in women. The key objectives are to: 1) Determine the association of HIV and menopausal phase with cardiovascular disease risk parameters; 2) Evaluate the association...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) will provide $896,013 to the Regents of the University of Michigan over a 5-year period from September 2024 to August 2029. The funding will support research to define the origins and evolution of mammalian sex chromosome dosage compensation mechanisms, which equalize X-linked gene expression between XX females and XY males. The research aims...
The University of California, San Diego (UCSD) has been awarded a $1,422,000 Project Grant by the National Institutes of Health (NIH) under the Trans-NIH Research Support (CFDA 93.310) program. The research project, titled "Probing Sex Differences in Myocardial Fibrosis at Multiple Length Scales Using Biomaterials," aims to investigate how biological sex modulates myocardial fibrosis and develop innovative models of sex-specific tissue remodeling using advanced biomaterial...
This Project Grant award of $601,563 was provided by the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), with a project period from September 1, 2024 to August 31, 2027. The award supports research to investigate the pathogenic roles and molecular mechanisms of the histone lysine demethylases KDM5A and KDM5B in the development and progression of heart failure, with a focus on hereditary cardiomyopathies like Lamin...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $115,949 to The Regents of the University of California, San Francisco (UCSF) to support research on the control of adipose immune-stromal niche topography in obesity. The primary objectives are to delineate adipose tissue topography using spatial sequencing, microscopy, and flow cytometry to identify novel signaling or cell...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $1,938,605 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to the Van Andel Research Institute (VAI) to investigate the mechanisms by which the X-linked chromatin modifying enzyme KDM5C regulates female bone mass. The goal is to determine how KDM5C transcriptionally programs genes that control osteoclast differentiation and function, and to assess whether KDM5C...